Bank Of America Corp Plus Therapeutics, Inc. Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.3 - $8.4 $11 - $327	39 New	39 $0
Q4 2021 Feb 08, 2022	SELL	$1.03 - $1.94 $2,291 - $4,316	-2,225 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.83 - $2.46 $4,053 - $5,448	2,215 Added 22150.0%	2,225 $4,000
Q2 2021 Sep 13, 2021	BUY	$2.0 - $2.89 $20 - $28	10 New	10 $0

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $46.4M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.